Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.

Hanqing LiuMan LuJiawei HuGuangzhao FuQinyu FengSheng-Rong SunChuang Chen

Published in: Therapeutics and clinical risk management (2023)

Lots of medications and food can impair the bioavailability of levothyroxine. Clinicians, patients and pharmaceutical companies should be aware of the possible interactions. Further well-designed studies are needed to provide more solid evidence on treatment and mechanisms.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
prognostic factors
palliative care
human health
risk assessment
climate change
combination therapy